CDKN2A and Parkinson disease: Higher mRNA levels of p16INK4a in the substantia nigra pars compacta (SNpc) were also observed in post‐mortem tissue of patients with Parkinson's disease (PD) compared to healthy controls (Chinta et al. 2018).